Purchase Order W81K0025PA216
- Not listed
- This contract award is for the delivery of a Cardiogen-82 generator, infusion system and accessories, as well as a HeartSee license, to the William Beaumont Army Medical Center. The award was made on October 1, 2023 to Bracco Diagnostics Inc., a foreign-owned, for-profit organization that specializes in diagnostic imaging products and services for the U.S. federal government. The contract has a ceiling value of $386,597.90 and is a firm fixed-price purchase order. It is not associated with a...
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Bracco Diagnostics Inc., a foreign-owned, for-profit organization, for the delivery of Cardiogen Rubidium RB-82 Generators. The $407,843.50 contract has an ultimate completion date of September 30, 2025. It is not associated with a set-aside program. Bracco Diagnostics is a global healthcare company that specializes in diagnostic imaging products and medical technologies, particularly in nuclear...
- This is a delivery order awarded to Bracco Diagnostics Inc., a foreign-owned for-profit organization, under the Department of Veterans Affairs (VA) Veterans Health Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The $735,032.77 firm fixed price order is for the supply of CARDIOGEN-82 rubidium generators used in cardiac positron emission tomography (PET) scans. Bracco Diagnostics, a leader in diagnostic imaging, provides a variety of radiopharmaceutical...
- This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Bracco Diagnostics Inc., a foreign-owned for-profit company. The contract is for the provision of a generator, a medical imaging device, with a potential value of $488,761.70. The order is placed against Bracco's Pharmaceuticals and Drugs Federal Supply Schedule contract with the VA. The contract has no set-aside designation. Bracco Diagnostics Inc. is a leading...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $409,650.92 firm fixed price delivery order to Bracco Diagnostics Inc., a foreign-owned for-profit organization, for the supply of CARDIOGEN-82. The delivery order was placed against Bracco's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, and the products will be delivered to VA facilities within Veterans Integrated Service Network 17 located in Dallas, TX. Bracco Diagnostics is a...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Bracco Diagnostics Inc., a foreign-owned for-profit organization, for the provision of a 3-month bridge contract for PET RB82 generators. The contract has a ceiling value of $111,239.92 and an ultimate completion date of September 8, 2023. Bracco Diagnostics is an international healthcare company that specializes in diagnostic imaging products and services. This award is part of a larger indefinite...
- This federal contract award to Bracco Diagnostics Inc., a foreign-owned for-profit organization, is for the provision of Cardiogen-82 generators and HeartSee software. The $432,456.56 firm-fixed-price contract was awarded by the Medical Command (MEDCOM) of the U.S. Army to support cardiac positron emission tomography (PET) imaging capabilities within the Veterans Affairs (VA) healthcare network. The contract has a period of performance through September 30, 2025 and was awarded on October 1,...
- This federal contract award to Bracco Diagnostics Inc., a foreign-owned for-profit organization, is a firm fixed-price delivery order under the Department of Veterans Affairs (VA) Veterans Health Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract, valued at $955,318.72, is for the provision of rubidium generators, radioactive tracers, and other radiopharmaceutical products to support medical imaging across the VA and Defense Health Agency (DHA) networks....
- This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Bracco Diagnostics Inc., a foreign-owned for-profit organization, under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The $359,763.30 award is for the lease of CARDIOGEN-82 infusion systems, accessories, and supplies to support cardiac PET scans at VA facilities in the Veterans Integrated Service Network 17 region. Bracco Diagnostics is...
- This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Bracco Diagnostics Inc., a foreign-owned for-profit company, to provide RB-82 generators for the VA's Integrated Service Network 23. The contract has a potential value of $385,776.00 and a completion date of September 30, 2021. The contract was awarded on November 5, 2020 and is not set-aside. Bracco Diagnostics Inc. is an international healthcare company that...
The Defense Health Agency awarded a $462,343.05 firm fixed-price purchase order to Bracco Diagnostics Inc. for cardiac infusions generators, radiopharmaceuticals, and supplies supporting coronary artery disease evaluation. The contract period runs from October 1, 2025 through September 30, 2026, with performance at Fort Bliss, Texas. This procurement was not set-aside for any particular business category and represents a continuation of Bracco's significant role as a federal supplier of advanced diagnostic imaging equipment and radioactive tracers to the Department of Defense health system. Bracco Diagnostics, an Italy-headquartered subsidiary specializing in radiopharmaceutical and medical imaging technologies, has established itself as a critical vendor for cardiac positron emission tomography systems across federal healthcare networks. The company maintains an extensive portfolio of Defense Health Agency and Veterans Affairs contracts, with prior awards ranging from $15,000 to over $1.7 million. This procurement specifically addresses the military health system's need for cardiac imaging capabilities, leveraging Bracco's specialized expertise in rubidium generators and related nuclear medicine equipment essential for diagnostic coronary artery disease evaluation at military treatment facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 9/8/25 |